Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Comment by postie1on Apr 27, 2024 6:01pm
71 Views
Post# 36011214

RE:RE:RE:RE:Potential?

RE:RE:RE:RE:Potential?This might possibly appeal to other drug companies (not just Barite or Iodine) as a gateway for their other drugs to be better known by getting their foot in the door or bundling. plus there is  a good possibility of taking a larger share of the market as remember that all estimates of market percentage was kept conservative. And VM does not know the true size of the FC deposit as drilling is supposed to be done to do just that..
And some company might see the potential of the C60 for possibly being a better drug carrying agent because if nanotach can be achieved then who knows how much better or efficient it could make drugs and be a superior contrast agent to barite( of course that has to be proven or disproven). So then the question becomes what percentage of the contrast market then? But remember that is most likely far down the road. I would be surprised if there are not already eyes on VM.
<< Previous
Bullboard Posts
Next >>